Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.

Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, Mutasa K, Ruff A, Ward B; ZVITAMBO Study Group..

Pediatr Infect Dis J. 2011 Jan;30(1):45-51. doi: 10.1097/INF.0b013e3181ecbf7e.

PMID:
21173675
2.

The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.

Taha TE, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR, Miotti PG.

Int J Epidemiol. 1995 Oct;24(5):1022-9.

PMID:
8557435
3.
4.

Child mortality according to maternal and infant HIV status in Zimbabwe.

Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, Moulton LH, Salama P, Ward BJ; ZVITAMBO Study Group..

Pediatr Infect Dis J. 2007 Jun;26(6):519-26.

PMID:
17529870
5.

Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.

Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M, Hutson D, Grimm K, et al.

Pediatrics. 1995 Sep;96(3 Pt 1):451-8.

PMID:
7651777
6.

Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.

Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, Germano P, Majid NA, Zimba I, Ceffa S, Palombi L.

Pediatr Infect Dis J. 2009 Jun;28(6):483-7. doi: 10.1097/INF.0b013e3181950c56.

PMID:
19483516
7.

The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.

Frederick T, Homans J, Spencer L, Kramer F, Stek A, Operskalski E, Kovacs A.

Clin Infect Dis. 2012 Sep;55(6):877-84. doi: 10.1093/cid/cis535.

PMID:
22675157
8.

Neurodevelopmental impairment among infants born to mothers infected with human immunodeficiency virus and uninfected mothers from three peri-urban primary care clinics in Harare, Zimbabwe.

Kandawasvika GQ, Ogundipe E, Gumbo FZ, Kurewa EN, Mapingure MP, Stray-Pedersen B.

Dev Med Child Neurol. 2011 Nov;53(11):1046-52. doi: 10.1111/j.1469-8749.2011.04126.x.

9.

Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.

Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA, Cruz ML, Losso MH, Read JS; National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study Group..

Pediatrics. 2007 Mar;119(3):e694-704.

PMID:
17296782
10.

Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group.

Spira R, Lepage P, Msellati P, Van De Perre P, Leroy V, Simonon A, Karita E, Dabis F.

Pediatrics. 1999 Nov;104(5):e56.

PMID:
10545582
11.

Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.

Guibert G, Warszawski J, Le Chenadec J, Blanche S, Benmebarek Y, Mandelbrot L, Tubiana R, Rouzioux C, Leruez-Ville M; French Perinatal Cohort..

Clin Infect Dis. 2009 Jun 1;48(11):1516-25. doi: 10.1086/598934.

PMID:
19388872
12.

Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.

Venkatesh KK, Lurie MN, Triche EW, De Bruyn G, Harwell JI, McGarvey ST, Gray GE.

Trop Med Int Health. 2010 Nov;15(11):1364-74. doi: 10.1111/j.1365-3156.2010.02634.x.

13.

Survival pattern among infants born to human immunodeficiency virus type-1 infected mothers and uninfected mothers in Harare, Zimbabwe.

Nathoo K, Rusakaniko S, Zijenah LS, Kasule J, Mahomed K, Mashu A, Choto R, Mbizvo M.

Cent Afr J Med. 2004 Jan-Feb;50(1-2):1-6. Erratum in: Cent Afr J Med. 2004 May-Jun;50(5-6):57.

PMID:
15490717
14.

Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.

Taron-Brocard C, Le Chenadec J, Faye A, Dollfus C, Goetghebuer T, Gajdos V, Labaune JM, Perilhou A, Mandelbrot L, Blanche S, Warszawski J; France REcherche Nord&Sud Sida-HIV Hepatites - Enquete Perinatale Francaise - CO1/CO11 Study Group..

Clin Infect Dis. 2014 Nov 1;59(9):1332-45. doi: 10.1093/cid/ciu586.

PMID:
25053719
15.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium..

Pediatrics. 2007 Apr;119(4):e900-6.

PMID:
17353299
16.

Mortality in the first 2 years among infants born to human immunodeficiency virus-infected women in Harare, Zimbabwe.

Zijenah L, Mbizvo MT, Kasule J, Nathoo K, Munjoma M, Mahomed K, Maldonado Y, Madzime S, Katzenstein D.

J Infect Dis. 1998 Jul;178(1):109-13.

PMID:
9652429
17.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.

18.

Perinatal human immunodeficiency virus-1 transmission and intrauterine growth: a cohort study in Butare, Rwanda.

Weng S, Bulterys M, Chao A, Stidley CA, Dushimimana A, Mbarutso E, Saah A.

Pediatrics. 1998 Aug;102(2):e24.

PMID:
9685470
19.

HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era.

Evans C, Humphrey JH, Ntozini R, Prendergast AJ.

Front Immunol. 2016 Jun 6;7:190. doi: 10.3389/fimmu.2016.00190.

20.

Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.

Kakkar F, Lamarre V, Ducruet T, Boucher M, Valois S, Soudeyns H, Lapointe N.

BMC Infect Dis. 2014 May 5;14:236. doi: 10.1186/1471-2334-14-236.

Items per page

Supplemental Content

Support Center